USP8, USP48, BRAF and TP53 mutations in crooke cell adenoma
Authors:
Open Access
- 5 October 2025
- journal article
- research article
- Published by Springer Nature in Pituitary
- Vol. 28 (5) , 1-5
Abstract
Purpose: Crooke cell adenomas (CCAs) are rare histological subtype of corticotroph pituitary adenomas (cPAs) commonly related to worse prognosis in patients. Notable progress in understanding of the molecular background of cPAs has been made recently but biology of CCAs remains poorly recognized. Results of our previous study suggested distinct frequency of the known recurrent mutations in CCAs than in sparsely and densely granulated cPAs. Thus, the aim was to determine the prevalence of USP8 , USP48 , BRAF and TP53 variants in a relatively large retrospective group of patients diagnosed with CCA. Methods: DNA was isolated from formalin-fixed and paraffin-embedded tissue of 29 CCAs (14 clinically functioning and 15 nonfunctioning). Sanger sequencing was used for the identification of USP8 , USP48 , BRAF hotspot variants, while semiconductor sequencing with Ion AmpliSeq TP53 Panel was used for analysis of TP53 sequence. Results: USP8 variants were found in 2 CCA patients with Cushing’s disease (CD), whereas 3 TP53 variants were identified in 1 CCA patient with CD and 2 patients with clinically nonfunctioning CCAs. USP8 variants are less frequent in clinically functioning CCAs than functioning sparsely and densely granulated corticotroph tumors ( p = 0.0271). TP53 variants are more common in CCAs as compared to other histological subtypes ( p = 0.0164). One BRAF V600E variant and no USP48 variant were found. Conclusion: CCAs have slightly distinct mutational profile then other histological subtypes of cPAs. Since clinical relevance of TP53 variants in corticotroph tumors was already documented, testing toward TP53 sequence changes in patients with CCAs should be considered.Keywords
Funding Information
- National Science Centre, Poland (2019/35/N/NZ5/03121)
This publication has 29 references indexed in Scilit:
- Prevalence and clinical associations of USP8 variants in corticotroph tumours: a systematic review and aggregate data meta-analysis of 2171 casesEuropean Journal of Endocrinology, 2025
- Assignment of the disordered, proline-rich N-terminal domain of the tumour suppressor p53 protein using 1HN and 1Hα-detected NMR measurementsBiomolecular NMR Assignments, 2023
- Functioning Crooke Cell Adenomas: Case Series and Literature ReviewWorld Neurosurgery, 2022
- Two Pituitary Neuroendocrine Tumors (PitNETs) with Very High Proliferation and TP53 Mutation — High-Grade PitNET or PitNEC?Endocrine Pathology, 2021
- Pangenomic Classification of Pituitary Neuroendocrine TumorsCancer Cell, 2020
- Ki-67 labeling index and expression of p53 are non-predictive for invasiveness and tumor size in functional and nonfunctional pituitary adenomasActa Neurochirurgica, 2019
- Identification of recurrent USP48 and BRAF mutations in Cushing’s diseaseNature Communications, 2018
- Recurrent gain-of-function USP8 mutations in Cushing's diseaseCell Research, 2015
- Mutations in the deubiquitinase gene USP8 cause Cushing's diseaseNature Genetics, 2014
- Role of Ki-67 proliferation index and p53 expression in predicting progression of pituitary adenomasHuman Pathology, 2008